Skip to main content
SpringerLink
Log in

Measles

  • Chapter
Nutrition and Health in Developing Countries

Part of the book series: Nutrition ◊ and ◊ Health ((NH))

  • 292 Accesses

Abstract

Despite the availability of a cheap and effective vaccine, measles remains a problem in developing countries. It is a leading childhood killer, accounting for more deaths than any other vaccine-preventable disease. This chapter discusses important epidemiological, clinical, and management issues that are relevant in developing countries. The association between measles and nutrition, particularly vitamin A is stressed. The need to reduce the disease burden through effective case management and immunization is highlighted.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Centers for Disease Control and Prevention (CDC). Progress toward global measles control and elimination, 1990–1996. MMWR 1997; 46: 893–897.

    Google Scholar 

  2. World Health Organization (WHO). Division of Diarrhoeal and Acute Respiratory Disease Control. Integrated management of the sick child. Bull WHO 1995; 73: 735–740.

    Google Scholar 

  3. Hussey GD, Clements CJ. Clinical problems in measles. Ann Trop Paed 1996; 16: 307–317.

    CAS  Google Scholar 

  4. Rhazes [Abu Bakr Muhammad ibn Zakariya al-Razil. A treatise on the smallpox and measles. Translated from the Arabic by William Alexander Greenhil. London: Sydenham Society, 1848.

    Google Scholar 

  5. Sydenham T. Observationes medicae circa morborum acutorum historiam et curationem. Londini: G. Kettilby, 1676.

    Google Scholar 

  6. Creighton C. A history of epidemics in Britain, 2 vols. Cambridge, UK: Cambridge University Press, 1894.

    Google Scholar 

  7. Hirsch A. Handbook of Geographical and Historical Pathology, 3 vols. London: New Sydenham Society, 1883.

    Google Scholar 

  8. Jannetta AB. Epidemics and mortality in early modern Japan. Princeton, NJ: Princeton University Press, 1987.

    Google Scholar 

  9. Panum PL. Observations made during the epidemic of measles in the Faroe Islands in the year 1846. Med Classics 1929; 3: 829–886.

    Google Scholar 

  10. Koplik H. The diagnosis of the invasion of measles from a study of the exanthema as it appears on the buccal mucous membrane. Arch Pediatr 1896; 13: 918–922.

    Google Scholar 

  11. Morley D, Woodland M, Martin WJ. Measles in Nigerian children: a study of the disease in West Africa, and its manifestations in England and other countries during different epochs. J Hyg Camb 1963; 61: 115–134.

    Article  CAS  Google Scholar 

  12. Morley D. Severe measles in the tropics-1. BMJ 1969; 1: 297–300, 363–365.

    Google Scholar 

  13. Aaby P. Malnutrition and overcrowding/intensive exposure in severe measles infection: review of community studies. Rev Infect Dis 1988; 10: 478–491.

    Article  CAS  Google Scholar 

  14. Barclay AJG, Foster A, Sommer A. Vitamin A supplements and mortality related to measles: a randomised clinical trial. BMJ 1987; 294: 294–296.

    Article  CAS  Google Scholar 

  15. Hussey GD, Klein M. A randomised controlled trial of vitamin A in children with severe measles. N Engl J Med 1990; 323: 160–164.

    Article  CAS  Google Scholar 

  16. WHO. Global Programme for Vaccines and Immunization. Treating measles in children. WHO/EPI/ TRAM/97. 02. Geneva: WHO, 1997.

    Google Scholar 

  17. Enders JF, Peebles TC. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med 1954; 86: 277–286.

    CAS  Google Scholar 

  18. Katz SL, Kempe CH, Black FL, et al. Studies on an attenuated measles-virus vaccine. V11. General summary and evaluation of the results of vaccination. N Engl J Med 1960; 273: 180–184.

    Article  Google Scholar 

  19. Sato H, Albrecht P, Reynolds DW, et al. Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps and rubella immunization. Am J Dis Child 1979; 133: 1240–1243.

    CAS  Google Scholar 

  20. Job JS, Halsey NA, Boulos R, et al. Successful immunization of infants at 6 months of age with high dose Edmonston-Zagreb measles vaccine. Pediatr Infect Dis J 1991; 10: 303–311.

    Article  CAS  Google Scholar 

  21. Garenne M, Leroy O, Beau JP, et al. Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet 1991; 338: 903–907.

    Article  CAS  Google Scholar 

  22. Aaby P, Samb B, Simondon F, et al. Divergent mortality for male and female recipients of low-titer and high-titer measles vaccine in rural Senegal. Am J Epidemiol 1993; 138: 746–755.

    CAS  Google Scholar 

  23. Hussey GD, Goddard EA, Hughes J, et al. The effect of Edmoonston-Zagreb and Schwarz measles vaccines on immune response in infants. J Infect Dis 1996; 173: 1320–1326.

    Article  CAS  Google Scholar 

  24. WHO. Expanded Programme on Immunication: Global Advisory Group. Wky Epidemiol Rec 1993; 68: 11–16.

    Google Scholar 

  25. Coetzee N. Hussey GD, Visser G, Barron P, Keen A. The 1992 measles epidemic in Cape Town: a changing epidemiological pattern. S Afr Med J 1994; 84: 145–149.

    CAS  Google Scholar 

  26. Clements CJ, Strassburg M, Cutts FT, Torel C. The epidemiology of measles. World Health Stat Q 1992; 45: 285–291.

    CAS  Google Scholar 

  27. WHO. Measles control in the 1990’s: Plan of action for global measles control. WHO/EPI/GEN/92. 3. Geneva, WHO, 1992.

    Google Scholar 

  28. Aaby P. Determinants of measles mortality: host or transmission factors, In Medical Virology, No. 10. de la Maza LM, ed. New York, NY: Plenum, 1991, pp. 83–116.

    Chapter  Google Scholar 

  29. Aaby P, Coovadia H. Severe measles: a reappraisal of the role of nutrition, overcrowding and virus dose. Med Hypotheses 1985; 18: 93–112.

    Article  CAS  Google Scholar 

  30. Anonymous. Immunology of measles. Lancet 1989; 2: 780–781.

    Google Scholar 

  31. Hussey GD, Klein M. Measles induced vitamin A deficiency. Ann NY Acad Sci 1992; 669: 188–196.

    Article  CAS  Google Scholar 

  32. Tomkins A, Hussey GD. Vitamin A, immunity and infection. Nutr Res Rev 1989; 2:17–28.

    Google Scholar 

  33. Stephensen CB, Alvarez JO, Kohatsu J, Hardmeier R, Kennedy JI, Gammon RD Vitamin A is excreted in the urine during acute infection. Am J Clin Nutr 1994; 60: 388–392.

    CAS  Google Scholar 

  34. Coovadia HM, Wesley A, Brain P. Immunological events in acute measles influencing outcome. Arch Dis Child 1978; 53: 861–867.

    Article  CAS  Google Scholar 

  35. Hull HF, Williams PJ, Oldfield F. Measles mortality and vaccine efficacy in rural West Africa. Lancet 1983; 1: 972–975.

    Article  CAS  Google Scholar 

  36. Markowitz LE, Nzilambi N, Diskell WJ, et al. Vitamin A levels and mortality among hospitalized measles patients. J Trop Paediatr 1989; 35: 109–112.

    Article  CAS  Google Scholar 

  37. Butler JC, Havens PL, Sowell AL, et al. Measles severity and serum retinol (vitamin A) concentration among children in the United States. Pediatrics 1993; 91: 1176–1181.

    CAS  Google Scholar 

  38. Frieden TF, Sowell AL, Henning KJ, Huff DL, Gunn RA. Vitamin A levels and severity of measles: New York City. Am J Dis Child 1992; 146: 182–186.

    Google Scholar 

  39. Reddy V. Interaction between nutrition and measles. Indian J Pediatr 1987; 54: 53–57.

    Article  CAS  Google Scholar 

  40. Dossetor JFB, Whittle HC. Protein-losing enteropathy and malabsorption in acute measles enteritis. BMJ 1975; 2: 592–593.

    Article  CAS  Google Scholar 

  41. Duggan MB, Milner RDG. Energy cost of measles infection. Arch Dis Child 1986; 61: 436–439.

    Article  CAS  Google Scholar 

  42. Axton JHM. Measles and the state of nutrition. S Afr Med J 1979; 55: 125–126.

    CAS  Google Scholar 

  43. Bhaskaram P, Reddy V, Ray S, Bhatnagar RC. Effect of measles on the nutritional status of preschool children. J Trop Med Hyg 1984; 87: 21–25.

    CAS  Google Scholar 

  44. Coomey JOO, Richardson JE. Measles in Ghana. Ann Trop Paediatr 1984; 4: 189–194.

    Google Scholar 

  45. Varavithya W, Charuvantji A, Tarounotai T, et al. Diarrhoea in measles. J Med Assoc Thai 1985; 68: 298–301.

    CAS  Google Scholar 

  46. Greenberg BL, Sack RB, Salazar-Lindo E, et al. Measles-associated diarrhea in hospitalized children in Lima, Peru: pathogenic agents and impact on growth. J Infect Dis 1991; 163: 495–502.

    Article  CAS  Google Scholar 

  47. Koster FT, Curlin GC, Aziz KMA, Hague A. Synergistic impact of measles and diarrhoea on nutrition and mortality in Bangladesh. Bull WHO 1981; 59: 901–908.

    CAS  Google Scholar 

  48. Hussey GD, Klein M. Measles. Child Hosp Q 2: 301–305.

    Google Scholar 

  49. Orren A, Kipps A, Moodie JW, et al. Increased susceptibility to herpes simplex virus infections in children with acute measles. Infect Immunol 1981; 31: 1–6.

    CAS  Google Scholar 

  50. Burgess W, Mduma B, Josephson GV. Measles in Mbeya, Tanzania, 1981–1983. J Trop Pediatr 1986; 32: 148–153.

    Article  CAS  Google Scholar 

  51. Samsi TK, Ruspandji T, Susanto I, Gunawan K. Risk factors for severe measles. Southeast Asian J Trop Med Public Health 1992; 23: 497–503.

    CAS  Google Scholar 

  52. Alwar AJE. The effect of protein energy malnutrition on morbidity and mortality due to measles at Kenyatta National Hospital, Nairobi, Kenya. East Afr Med J 1992; 69: 415–418.

    CAS  Google Scholar 

  53. Dossetor J, Whittle HC, Greenwood BM. Persistent measles infection in malnourished children. BMJ 1977; 1: 1633–1635.

    Article  CAS  Google Scholar 

  54. Foster A, Sommer A. Corneal ulceration, measles, and childhood blindness in Tanzania. Br J Ophthal 1987; 71: 331–343.

    Article  CAS  Google Scholar 

  55. Tidstrom B. Complications in measles with special reference to encephalitis. Acta Med Scand 1968; 184: 411–415.

    Article  CAS  Google Scholar 

  56. Miller DL. Frequency of complications of measles. BMJ 1964; 2: 75–78.

    Article  CAS  Google Scholar 

  57. Zilber N, Rannon L, Alter M, Kahana E. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE). Neurology 1983; 33: 1558–1564.

    CAS  Google Scholar 

  58. Burstrom B, Aaby P, Mutie DM, Kimani G, Bjerregaard P. Severe measles outbreak in Western Kenya. E Afr Med J 1992; 69: 419–423.

    CAS  Google Scholar 

  59. Markowitz LE, Chandler FW, Roldan EO, et al. Fatal measles pneumonia without a rash: in a child with AIDS. J Infect Dis 1988; 158: 480–483.

    Article  CAS  Google Scholar 

  60. Palumbo P, Hoyt L, Demasio K, Oleske J, Connor E. Population-based study of measles and measles immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1992; 11: 1008–1114.

    Article  CAS  Google Scholar 

  61. Ellison JB. Intensive vitamin therapy in measles. Br M J 1932; 2: 708–711.

    Article  CAS  Google Scholar 

  62. Coutsoudis A, Broughton M, Coovadia HM. Vitamin A supplementation reduces measles morbidity in young African children: a randomised, placebo-controlled, double-blind trial. Am J Clin Nutr 1991; 54: 890–895.

    CAS  Google Scholar 

  63. Ogaro FO, Orinda VA Onyango F, Black RE. Effect of vitamin A on diarrhoeal and respiratory complications of measles. Trop Geogr Med 1993; 45: 283–286.

    CAS  Google Scholar 

  64. Madhulika, Kabra SK, Talati A. Vitamin A supplementation in post-measles complications. J Trop Pediatr 1994; 40: 305–307.

    Article  Google Scholar 

  65. Rosales FJ, Kjolhede C, Goodman L. Efficacy of a single oral dose of 200,000 IU of oil-soluble vitamin A in measles-associated morbidity. Am J Epidemiol 1996; 143: 413–422.

    Article  CAS  Google Scholar 

  66. WHO. Case management of measles: a policy document. Geneva: WHO, 1996.

    Google Scholar 

  67. Shann F. Meta-analysis of trials of prophylactic antibiotics for children with measles: inadequate evidence. BMJ 1997; 314: 334–336.

    Article  CAS  Google Scholar 

  68. Hussey GD. Managing measles. Integrated management reduces disease severity. BMJ 1997; 314: 316–317.

    Article  CAS  Google Scholar 

  69. Glasziou PP, Mackerras DEM. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ 1993; 306: 366–370.

    Article  CAS  Google Scholar 

  70. Rahmathullah L, Underwood B, Thulasiraj RD, et al. Reduced mortality among children in Southern India receiving a small weekly dose of vitamin A. N Engl J Med 1990; 323: 929–935.

    Article  CAS  Google Scholar 

  71. West KP Jr., Pokhrel RP, Katz J, et al. Efficacy of vitamin A in reducing pre-school child mortality in Nepal. Lancet 1991; 338: 67–71.

    Article  Google Scholar 

  72. Daulaire NM, Starbuck ES, Houston RM, Church MS, Stukel TA, Pandey MR. Childhood mortality after a high dose of vitamin A in a high risk population. BMJ 1992; 304: 207–210.

    Article  CAS  Google Scholar 

  73. Beaton GH, Martorell R, Aronson KJ, et al. Effectiveness of vitamin A supplementation in the control of young child morbidity and mortality in developing countries. Discussion paper no. 13. Geneva: Administrative Committee on Coordination/Subcommittee on Nutrition (ACC/SCN ), 1993.

    Google Scholar 

  74. Hussey GD, Klein M. Routine high dose vitamin A therapy for children hospitalized with measles. J Trop Paeds 1993; 39: 342–345.

    Article  CAS  Google Scholar 

  75. Preblud SR, Katz SL. Measles vaccine. In: Vaccines. Plotkin SA, Mortimer EA, eds. Philadelphia, WB Saunders: 1988, pp. 182–211.

    Google Scholar 

  76. World Health Organization: Global programme for vaccines and immunization. Immunization policy. WHO/EPI/GEN/95.03 REV. 1. Geneva, WHO, 1995.

    Google Scholar 

  77. Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998; 47 (RR-8): 1–57.

    CAS  Google Scholar 

  78. Arpadi SM, Markowitz LE, Baughman AL, et al. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Pediatrics 1996; 97: 653–657.

    CAS  Google Scholar 

  79. CDC. Advances in global measles control and elimination: summary of the 1997 international meeting. MMWR 1998; 47 (RR-11): 1–23.

    Google Scholar 

  80. World Summit for Children—Mid-decade goal: VAD. JCHPSS/94/2.8. Geneva: UNICEF-WHO Joint Committee on Health Policy Special Session, 27–28 January, 1994.

    Google Scholar 

  81. WHO. Using immunization contacts as the gateway to eliminating vitamin A deficiency. WHO/EPI/ GEN/94.9. Geneva: WHO, 1994.

    Google Scholar 

  82. Semba RD, Akib A, Beeler J, et al. Effect of vitamin A supplementation on measles vaccination in nine-month-old infants. Public Health 1997; 111: 245–247.

    CAS  Google Scholar 

  83. Benn CS, Aaby P, Bale C, et al. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, West Africa. Lancet 1997; 350: 101–105.

    Article  CAS  Google Scholar 

  84. WHO and United Nations International Children’s Emergency Fund (UNICEF). Measles in state of the world’s vaccines and immunization. Geneva: WHO, 1996, pp. 39–44.

    Google Scholar 

  85. WHO. Clinical research on treatment of measles: report of a meeting. WHO/CDR/95. 15. Geneva: WHO, 1995.

    Google Scholar 

Download references

Authors
  1. Gregory Hussey
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, Division of Ocular Immunology, Johns Hopkins School of Medicine, Baltimore, MD, USA

    Richard D. Semba MD, MPH

  2. Helen Keller International — Regional Headquarters, Jakarta, Indonesia

    Martin W. Bloem MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hussey, G. (2001). Measles. In: Semba, R.D., Bloem, M.W. (eds) Nutrition and Health in Developing Countries. Nutrition ◊ and ◊ Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-225-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-225-8_7

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-6052-1

  • Online ISBN: 978-1-59259-225-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation